1. Home
  2. BY vs HROW Comparison

BY vs HROW Comparison

Compare BY & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BY

Byline Bancorp Inc.

HOLD

Current Price

$29.21

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$45.61

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BY
HROW
Founded
1914
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BY
HROW
Price
$29.21
$45.61
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$33.67
$68.86
AVG Volume (30 Days)
197.2K
712.5K
Earning Date
01-22-2026
11-10-2025
Dividend Yield
1.37%
N/A
EPS Growth
1.54
N/A
EPS
2.80
N/A
Revenue
$400,663,000.00
$250,042,000.00
Revenue This Year
$19.26
$39.05
Revenue Next Year
$3.88
$40.48
P/E Ratio
$10.42
N/A
Revenue Growth
7.23
47.83
52 Week Low
$22.63
$20.85
52 Week High
$32.05
$50.72

Technical Indicators

Market Signals
Indicator
BY
HROW
Relative Strength Index (RSI) 65.80 65.36
Support Level $27.82 $39.64
Resistance Level $28.45 $42.44
Average True Range (ATR) 0.55 2.33
MACD 0.21 0.85
Stochastic Oscillator 90.54 80.37

Price Performance

Historical Comparison
BY
HROW

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: